Zhejiang Medicine Co., Ltd. (600216) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Zhejiang Medicine Co., Ltd. Company Snapshot

Business Description:

Zhejiang Medicine Co., Ltd. operates in the Pharmaceutical preparations sector. Zhejiang Medicine Co., Ltd. is principally engaged in the distribution of drug substances, finished formulations and food. The Company offers synthetic vitamin E, natural vitamin E soft capsules, levofloxacin lactate tablets, vitamin A, Beta carotene, vancomycin hydrochloride for injection, progesterone soft capsules and teicoplanin for injection. The Company also provides intermediate products and nourishment for human beings and animals. The Company distributes its products within China and to overseas markets. In our complete report available for purchase the company is compared to: Joincare Pharmaceutical Group Industry Company Limited, Tianjin Tasly Pharmaceutical Co., Ltd. and Sanjiu Medical & Pharmaceutical Co., Ltd..

Zhejiang Medicine Co., Ltd.

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 20.97
(Figures in Chinese Renmimbi)

1 Week	n/a	13 Weeks	11.6%

4 Weeks	-23.4%	52 Weeks	-32.3%

Zhejiang Medicine Co., Ltd. Key Data:

Ticker:	600216	Country:	CHINA

Exchanges:	SHG	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	4,558,265,000 (Year Ending Jan 2011).	Employees:	4,205

Currency:	Chinese Renmimbi	Market Cap:	9,437,758,200

Fiscal Yr Ends:	December	Shares Outstanding:	450,060,000

Share Type:	A Gu	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.